Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects
Clinical trial NCT03183739 · COMPLETED
Trial details
- NCT number
- NCT03183739
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2017-10-06
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.